Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
11335 | 990 | 30.8 | 83% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
8 | 4 | CARDIAC & CARDIOVASCULAR SYSTEM//PERIPHERAL VASCULAR DISEASES//CARDIOL | 1276458 |
131 | 3 | HEMATOLOGY//HAEMOPHILIA//TRANSFUSION | 66936 |
767 | 2 | WARFARIN//CYP2C9//VKORC1 | 12292 |
11335 | 1 | RECOMBINANT ACTIVATED FACTOR VII//RECOMBINANT FACTOR VIIA//RFVIIA | 990 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | RECOMBINANT ACTIVATED FACTOR VII | authKW | 2079694 | 12% | 57% | 119 |
2 | RECOMBINANT FACTOR VIIA | authKW | 1546386 | 12% | 43% | 117 |
3 | RFVIIA | authKW | 1291702 | 10% | 42% | 99 |
4 | NOVOSEVEN | authKW | 692152 | 4% | 61% | 37 |
5 | FACTOR VIIA | authKW | 563377 | 8% | 23% | 78 |
6 | RECOMBINANT ACTIVATED FACTOR VII RFVIIA | authKW | 440592 | 2% | 71% | 20 |
7 | RECOMBINANT FVIIA | authKW | 232747 | 2% | 38% | 20 |
8 | RECOMBINANT FACTOR VLLA | authKW | 215896 | 1% | 100% | 7 |
9 | RECOMBINANT ACTIVATED FACTOR VIIA | authKW | 207320 | 1% | 61% | 11 |
10 | RECOMBINANT FACTOR VII | authKW | 156131 | 1% | 56% | 9 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Hematology | 17132 | 40% | 0% | 397 |
2 | Anesthesiology | 4223 | 13% | 0% | 125 |
3 | Peripheral Vascular Diseases | 2607 | 16% | 0% | 154 |
4 | Critical Care Medicine | 2566 | 10% | 0% | 101 |
5 | Surgery | 643 | 15% | 0% | 153 |
6 | Respiratory System | 512 | 6% | 0% | 64 |
7 | Cardiac & Cardiovascular System | 311 | 8% | 0% | 81 |
8 | Pediatrics | 234 | 6% | 0% | 62 |
9 | Emergency Medicine | 188 | 2% | 0% | 20 |
10 | Medicine, General & Internal | 135 | 7% | 0% | 70 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | SO ALBERTA HEMOPHILIA CLIN | 70091 | 1% | 45% | 5 |
2 | COAGULAT ADVANCEMENT | 69394 | 0% | 75% | 3 |
3 | BIOPHARMACEUT UNIT | 64286 | 1% | 15% | 14 |
4 | INTERDISZIPLINARE INTERNIST INTENSIVMED | 61685 | 0% | 100% | 2 |
5 | CENT VIRGINIA COAGULAT DISORDERS | 59306 | 1% | 38% | 5 |
6 | EXPLORATORY ADME | 45349 | 1% | 29% | 5 |
7 | HAEMOSTASIS BIOL | 42829 | 1% | 28% | 5 |
8 | NOVO NORDISK PK | 41122 | 0% | 67% | 2 |
9 | ZENTRUM HAMOSTASEOL | 41122 | 0% | 67% | 2 |
10 | HAEMOSTASIS PHARMACOL | 32893 | 0% | 27% | 4 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | BLOOD COAGULATION & FIBRINOLYSIS | 61649 | 8% | 2% | 81 |
2 | SEMINARS IN HEMATOLOGY | 7830 | 2% | 1% | 22 |
3 | JOURNAL OF THROMBOSIS AND HAEMOSTASIS | 7540 | 3% | 1% | 31 |
4 | HAEMOPHILIA | 3217 | 2% | 1% | 18 |
5 | JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA | 3198 | 2% | 1% | 20 |
6 | THROMBOSIS AND HAEMOSTASIS | 3125 | 3% | 0% | 32 |
7 | SRPSKI ARHIV ZA CELOKUPNO LEKARSTVO | 2766 | 1% | 1% | 10 |
8 | CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS | 2271 | 1% | 1% | 11 |
9 | PATHOPHYSIOLOGY OF HAEMOSTASIS AND THROMBOSIS | 2126 | 1% | 1% | 5 |
10 | JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE | 2035 | 3% | 0% | 28 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | RECOMBINANT ACTIVATED FACTOR VII | 2079694 | 12% | 57% | 119 | Search RECOMBINANT+ACTIVATED+FACTOR+VII | Search RECOMBINANT+ACTIVATED+FACTOR+VII |
2 | RECOMBINANT FACTOR VIIA | 1546386 | 12% | 43% | 117 | Search RECOMBINANT+FACTOR+VIIA | Search RECOMBINANT+FACTOR+VIIA |
3 | RFVIIA | 1291702 | 10% | 42% | 99 | Search RFVIIA | Search RFVIIA |
4 | NOVOSEVEN | 692152 | 4% | 61% | 37 | Search NOVOSEVEN | Search NOVOSEVEN |
5 | FACTOR VIIA | 563377 | 8% | 23% | 78 | Search FACTOR+VIIA | Search FACTOR+VIIA |
6 | RECOMBINANT ACTIVATED FACTOR VII RFVIIA | 440592 | 2% | 71% | 20 | Search RECOMBINANT+ACTIVATED+FACTOR+VII+RFVIIA | Search RECOMBINANT+ACTIVATED+FACTOR+VII+RFVIIA |
7 | RECOMBINANT FVIIA | 232747 | 2% | 38% | 20 | Search RECOMBINANT+FVIIA | Search RECOMBINANT+FVIIA |
8 | RECOMBINANT FACTOR VLLA | 215896 | 1% | 100% | 7 | Search RECOMBINANT+FACTOR+VLLA | Search RECOMBINANT+FACTOR+VLLA |
9 | RECOMBINANT ACTIVATED FACTOR VIIA | 207320 | 1% | 61% | 11 | Search RECOMBINANT+ACTIVATED+FACTOR+VIIA | Search RECOMBINANT+ACTIVATED+FACTOR+VIIA |
10 | RECOMBINANT FACTOR VII | 156131 | 1% | 56% | 9 | Search RECOMBINANT+FACTOR+VII | Search RECOMBINANT+FACTOR+VII |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | PHILLIPS, LE , ZATTA, AJ , SCHEMBRI, NL , NOONE, AK , ISBISTER, J , (2009) UNCONTROLLED BLEEDING IN SURGICAL PATIENTS: THE ROLE OF RECOMBINANT ACTIVATED FACTOR VIIA.CURRENT DRUG TARGETS. VOL. 10. ISSUE 8. P. 744-770 | 173 | 92% | 3 |
2 | MALLARKEY, G , BRIGHTON, T , THOMSON, A , KAYE, K , SEALE, P , GAZARIAN, M , (2008) AN EVALUATION OF EPTACOG ALFA IN NONHAEMOPHILIAC CONDITIONS.DRUGS. VOL. 68. ISSUE 12. P. 1665-1689 | 89 | 92% | 12 |
3 | YANK, V , TUOHY, CV , LOGAN, AC , BRAVATA, DM , STAUDENMAYER, K , EISENHUT, R , SUNDARAM, V , MCMAHON, D , OLKIN, I , MCDONALD, KM , ET AL (2011) SYSTEMATIC REVIEW: BENEFITS AND HARMS OF IN-HOSPITAL USE OF RECOMBINANT FACTOR VIIA FOR OFF-LABEL INDICATIONS.ANNALS OF INTERNAL MEDICINE. VOL. 154. ISSUE 8. P. 529 -540 | 63 | 74% | 103 |
4 | HONG, I , STACHNIK, J , (2010) UNLABELED USES OF FACTOR VIIA (RECOMBINANT) IN PEDIATRIC PATIENTS.AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY. VOL. 67. ISSUE 22. P. 1909-1919 | 62 | 94% | 3 |
5 | SIMPSON, E , LIN, YL , STANWORTH, S , BIRCHALL, J , DOREE, C , HYDE, C , (2012) RECOMBINANT FACTOR VIIA FOR THE PREVENTION AND TREATMENT OF BLEEDING IN PATIENTS WITHOUT HAEMOPHILIA.COCHRANE DATABASE OF SYSTEMATIC REVIEWS. VOL. . ISSUE 3. P. - | 68 | 77% | 9 |
6 | FRANCHINI, M , (2006) RECOMBINANT FACTOR VIIA: A REVIEW ON ITS CLINICAL USE.INTERNATIONAL JOURNAL OF HEMATOLOGY. VOL. 83. ISSUE 2. P. 126-138 | 96 | 60% | 14 |
7 | RAMA-MACEIRAS, P , INGELMO-INGELMO, I , FABREGAS-JULIA, N , HERNANDEZ-PALAZON, J , (2011) THE ROLE OF RECOMBINANT ACTIVATED FACTOR VII IN NEUROSURGICAL AND NEUROCRITICAL PATIENTS.NEUROCIRUGIA. VOL. 22. ISSUE 3. P. 209-223 | 75 | 65% | 1 |
8 | FRANCHINI, M , ZAFFANELLO, M , VENERI, D , (2005) RECOMBINANT FACTOR VIIA - AN UPDATE ON ITS CLINICAL USE.THROMBOSIS AND HAEMOSTASIS. VOL. 93. ISSUE 6. P. 1027-1035 | 81 | 62% | 48 |
9 | GUZZETTA, NA , RUSSELL, IA , WILLIAMS, GD , (2012) REVIEW OF THE OFF-LABEL USE OF RECOMBINANT ACTIVATED FACTOR VII IN PEDIATRIC CARDIAC SURGERY PATIENTS.ANESTHESIA AND ANALGESIA. VOL. 115. ISSUE 2. P. 364-378 | 57 | 76% | 10 |
10 | LIN, YL , STANWORTH, S , BIRCHALL, J , DOREE, C , HYDE, C , (2011) RECOMBINANT FACTOR VIIA FOR THE PREVENTION AND TREATMENT OF BLEEDING IN PATIENTS WITHOUT HAEMOPHILIA.COCHRANE DATABASE OF SYSTEMATIC REVIEWS. VOL. . ISSUE 2. P. - | 50 | 81% | 12 |
Classes with closest relation at Level 1 |